Cargando…
Computational modeling and biomarker studies of pharmacological treatment of Alzheimer's disease
Alzheimer's disease (AD) is a complex and multifactorial disease. In order to understand the genetic influence in the progression of AD, and to identify novel pharmaceutical agents and their associated targets, the present study discusses computational modeling and biomarker evaluation approach...
Autores principales: | Hassan, Mubashir, Abbas, Qamar, Seo, Sung-Yum, Shahzadi, Saba, Ashwal, Hany Al, Zaki, Nazar, Iqbal, Zeeshan, Moustafa, Ahmed A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6059694/ https://www.ncbi.nlm.nih.gov/pubmed/29845262 http://dx.doi.org/10.3892/mmr.2018.9044 |
Ejemplares similares
-
Molecular Docking and Dynamic Simulation of AZD3293 and Solanezumab Effects Against BACE1 to Treat Alzheimer's Disease
por: Hassan, Mubashir, et al.
Publicado: (2018) -
Development of highly potent melanogenesis inhibitor by in vitro, in vivo and computational studies
por: Abbas, Qamar, et al.
Publicado: (2017) -
Computational prognostic evaluation of Alzheimer’s drugs from FDA-approved database through structural conformational dynamics and drug repositioning approaches
por: Hassan, Mubashir, et al.
Publicado: (2023) -
Applying Big Data Methods to Understanding Human Behavior and Health
por: Moustafa, Ahmed A., et al.
Publicado: (2018) -
Exploration of Potential Ewing Sarcoma Drugs from
FDA-Approved Pharmaceuticals through Computational Drug Repositioning,
Pharmacogenomics, Molecular Docking, and MD Simulation Studies
por: Hassan, Mubashir, et al.
Publicado: (2022)